( en | de | ru )

 

Disambiguierung von "Suissa, Samy"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding.

, , und . European journal of epidemiology, 27 (2): 77-83 (Februar 2012)6578<m:linebreak></m:linebreak>JID: 8508062; 2011/03/28 received; 2011/11/23 accepted; 2011/12/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models.
DOI: 10.1007/s10654-011-9637-7

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Joseph Selvaraj Samy

Mohamed Tayiser Mohamed Mousa Samy

Samy Mostafa

Samy Shamy

Samy Gallego

 

Weitere Publikationen von Autoren mit dem selben Namen

Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs., , , , und . Pharmacoepidemiology and drug safety, 16 (8): 845-9 (August 2007)4654<m:linebreak></m:linebreak>LR: 20081121; JID: 9208369; 0 (Central Nervous System Agents); 12794-10-4 (Benzodiazepines); CIN: Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):850-3. PMID: 17636552; ppublish;<m:linebreak></m:linebreak>Mesures d&#039;associació.Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies., , , , und . Diabetes care, 39 (3): 486-94 (März 2016)Critical appraisal; Bias; Observacionals; Diabetis; Oncologia<br/><br/>Bons gràfics de time bias al material suplementari.Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , und 17 andere Autor(en). 329 (16): 1376 (2023)Immortal time bias in observational studies of drug effects.. Pharmacoepidemiology and drug safety, 16 (3): 241-9 (März 2007)4793<m:linebreak></m:linebreak>LR: 20071115; CI: (c) 2007; JID: 9208369; 0 (Adrenergic beta-Agonists); 0 (Gastrointestinal Agents); CIN: Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):1036. PMID: 18816873; ppublish;<m:linebreak></m:linebreak>Mesures d&#039;associació; Immortal time bias.ACE-I and ARBs in early diabetic nephropathy., , , , , , , , , und . Journal of the renin-angiotensin-aldosterone system : JRAAS, (xx 12 2002)Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores., , und . Pharmacoepidemiology and drug safety, 26 (4): 459-468 (April 2017)Propensity score; CER; New-user designs; Diabetis.The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding., , und . European journal of epidemiology, 27 (2): 77-83 (Februar 2012)6578<m:linebreak></m:linebreak>JID: 8508062; 2011/03/28 received; 2011/11/23 accepted; 2011/12/08 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models.How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias., , , , , und . Pharmacoepidemiology and drug safety, (Januar 2019)Databases; Anàlisi de dades.Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?. Diabetes care, 41 (1): 6-10 (Januar 2018)Mesures d'associació; Immortal time bias; Diabetis.Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals., , , , , , , , , und 38 andere Autor(en). Annals of the American Thoracic Society, 16 (1): 22-28 (Januar 2019)Causalitat; Confounding; Introductori<br/><br/>Bona Figura i recursos.